<SEC-DOCUMENT>0000950170-25-058788-index.html : 20250425
<SEC-HEADER>0000950170-25-058788.hdr.sgml : 20250425
<ACCEPTANCE-DATETIME>20250425163342
ACCESSION NUMBER:		0000950170-25-058788
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250425
DATE AS OF CHANGE:		20250425
EFFECTIVENESS DATE:		20250425

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Axsome Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001579428
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				454241907
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37635
		FILM NUMBER:		25874682

	BUSINESS ADDRESS:	
		STREET 1:		ONE WORLD TRADE CENTER, 29TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10007
		BUSINESS PHONE:		(212) 332-3241

	MAIL ADDRESS:	
		STREET 1:		ONE WORLD TRADE CENTER, 29TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10007
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>axsm_fy2024_ars.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: axsm_fy2024_ars.pdf

</DOCUMENT>
</SEC-DOCUMENT>